Xenotech: Xenotech Announces The Addition Of In Vitro Toxicology To Its Extensive Portfolio Of Drug Development Services; Appoints As Principal Scientist Of Newly Formed Department

Lenexa, KS (July 14, 2015) Contract Research Organization XenoTech, LLC, a division of Sekisui, announces the addition of in vitro toxicology to its global drug development service portfolio. The company is launching the ECVAM validated skin irritation screening assay (OECD TG 439) immediately, with additional screens for skin sensitization, ocular irritation and other organotypic models beginning...